Showing results (161-170 of 463) with videos related to
Sort By:
Pageof 47
Journal of Neurochemistry|June 18, 2002
5-s-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neuronsJeremy P E Spencer, Matthew Whiteman, Peter Jenner, et al.Expert Review of Neurotherapeutics|January 28, 2021
Istradefylline - a first generation adenosine A2A antagonist for the treatment of Parkinson's diseasePeter Jenner, Akihisa Mori, Stephen D Aradi, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|October 15, 2025
Apomorphine differentially engages the cAMP and β-arrestin signaling pathways relative to dopamine at human dopamine receptorsBrittney Yegla, Jonathan Rubin, Mindy Grall, et al.Brain Research|October 18, 2002
Effects of short- and long-term (--)-deprenyl administration on mRNA for copper, zinc- and manganese-superoxide dismutase and glutathione peroxidase in rat brainGrazyna Kunikowska, Imelda Gallagher, Vivette Glover, et al.CNS Drugs|November 4, 2020
Improving the Delivery of Levodopa in Parkinson's Disease: A Review of Approved and Emerging TherapiesDaniele Urso, K Ray Chaudhuri, Mubasher A Qamar, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|May 18, 2012
Proteasome inhibition leads to early loss of synaptic proteins in neuronal cultureNatasha Bajic, Peter Jenner, Clive G Ballard, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|July 21, 2026
Population pharmacokinetic analyses comparing immediate-release levodopa/carbidopa, controlled-release levodopa/carbidopa, and IPX203. Findings from a phase 1 study in healthy volunteersAchim Wach, Jaakko Kopra, Ivan Marjanovic, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 24, 2016
Mavoglurant in Parkinson's patients with l-Dopa-induced dyskinesias: Two randomized phase 2 studiesClaudia Trenkwalder, Fabrizio Stocchi, Werner Poewe, et al.Pharmacology, Biochemistry, and Behavior|November 9, 2013
Antidepressant-like activity of the adenosine A(2A) receptor antagonist, istradefylline (KW-6002), in the forced swim test and the tail suspension test in rodentsKoji Yamada, Minoru Kobayashi, Akihisa Mori, et al.Journal of Neurochemistry|November 9, 2002
Proteasomal dysfunction induced by 4-hydroxy-2,3-trans-nonenal, an end-product of lipid peroxidation: a mechanism contributing to neurodegeneration?Dong-Hoon Hyun, Moon-Hee Lee, Barry Halliwell, et al.Pageof 47